CG Oncology formerly known as Cold Genesys is a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies. CG Oncology acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.

Legal

Sales & Business Development

Operations

Data Science

Quality Assurance

Irvine, CA, USA

CG Oncology

Camford Capital Management LLC

Camford Capital

Discover opportunities across our network

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Camford Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Camford network as they come up.

You can always update this information later.

Welcome to the Camford talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Camford company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Jobs